Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 11 HKD 4.96% Market Closed
Market Cap: 23.1B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Genscript Biotech Corp
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genscript Biotech Corp
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Genscript Biotech Corp
HKEX:1548
Net Change in Cash
-$998m
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Net Change in Cash
ÂĄ114.5m
CAGR 3-Years
-75%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Net Change in Cash
-ÂĄ91.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Net Change in Cash
ÂĄ1.8B
CAGR 3-Years
-38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Net Change in Cash
-ÂĄ5.4B
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
-32%
W
WuXi XDC Cayman Inc
HKEX:2268
Net Change in Cash
ÂĄ3.7B
CAGR 3-Years
432%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Genscript Biotech Corp
Glance View

Market Cap
23.3B HKD
Industry
Life Sciences Tools & Services

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2015-12-30. The firm operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.

Intrinsic Value
32.97 HKD
Undervaluation 67%
Intrinsic Value
Price

See Also

What is Genscript Biotech Corp's Net Change in Cash?
Net Change in Cash
-998m USD

Based on the financial report for Jun 30, 2024, Genscript Biotech Corp's Net Change in Cash amounts to -998m USD.

What is Genscript Biotech Corp's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-23%

Back to Top